1. National Health Care Anti-Fraud Association. The Challenge of Health Care Fraud. 2021. Available at: https://www.nhcaa.org/tools-insights/about-health-care-fraud/the-challenge-of-health-care-fraud/
2. Bagdoyan S.J. Medicare Actions Needed to Better Manage Fraud Risks. Washington, DC: United States Government Accountability Office; 2018.12
3. Jakovljevic, M., Timofeyev, Y., Ranabhat, C. L., Fernandes, P. O., Teixeira, J. P., Rancic, N., Reshetnikov, V. Real GDP growth rates and healthcare spending–comparison between the G7 and the EM7 countries. Globalization and Health. 2020; 16(1), 1-13.
4. Jakovljevic, M., Potapchik, E., Popovich, L., Barik, D., Getzen, T. E. (2017). Evolving health expenditure landscape of the BRICS nations and projections to 2025. Health Economics. 2017; 26(7): 844-852.
5. Jakovljevic, M., Lamnissos, D., Westerman, R., Chattu, V. K., Cerda, A. Future health spending forecast in leading emerging BRICS markets in 2030 – health policy implications. Health Research Policy and Systems. 2021. https://doi.org/10.21203/rs.3.rs-666830/v1
6. Braithwaite J. Corporate Crime in the Pharmaceutical Industry. London: Routledge & Kegan Paul pic; 1984. ISBN 0-7102-0049-8.
7. Dukes G., Braithwaite J., Maloney J.P. Pharmaceuticals, Corporate Crime and Public Health. Cheltenham: Edward Elgar Publishing; 2014. ISBN 9781784713614.
8. Robinson C. Tuscaloosa pharmaceutical sales rep gets federal prison in health insurance billing fraud scheme. 2021. Available at: https://www.al.com/news/birmingham/2021/04/tuscaloosa-pharmaceutical-sales-rep-gets-federal-prison-in-scheme-designed-to-fraudulently-bill-health-insurance-plans.html.
9. Parodi E. Italy judge sends Bayer, Novartis to trial in drugs fraud probe - sources. 2021. Available at: https://www.reuters.com/world/europe/italy-judge-sends-bayer-novartis-trial-drugs-fraud-probe-sources-2021-04-27/
10. U.S. Department of Justice. Five New Guilty Pleas in Nationwide Telemedicine Pharmacy Health Care Fraud Conspiracy. 2021. Available at: https://www.justice.gov/usao-edtn/pr/five-new-guilty-pleas-nationwide-telemedicine-pharmacy-health-care-fraud-conspiracy
11. Rashidian A., Joudaki H., Vian T. No evidence of the effect of the interventions to combat health care fraud and abuse: a systematic review of literature. PloS One. 2012; 7(8).
12. Abood R., Burns K. Pharmacy Practice and the Law. Burlington, MA: Jones and Barlett Learning. 2017; 8.
13. The U.S. Food and Drug Administration. 2021. Available at: https://www.fda.gov/regulatory-information/federal-food-drug-and-cosmetic-act-fdc-act/fdc-act-chapter-v-drugs-and-devices
14. Konijn R.M., Kowalczyk W. Finding fraud in health insurance data with two-layer outlier detection approach. In: International Conference on Data Warehousing and Knowledge Discovery. 2011: 394-405.
15. Liu J., Bier E., Wilson A., Guerra-Gomez J.A., Honda T., Sricharan K., Davies D. Graph analysis for detecting fraud, waste, and abuse in healthcare data. AI Magazine. 2016; 37(2): 33-46.
16. Kennedy J. P., Haberman C. P., Wilson J. M. Occupational pharmaceutical counterfeiting schemes: A crime scripts analysis. Victims & Offenders. 2018; 13(2): 196-214.
17. Qureshi Z.P., Sartor O., Xirasagar S., Liu Y., Bennett, C.L. Pharmaceutical fraud and abuse in the United States, 1996-2010. Archives of Internal Medicine. 2011; 171(16): 1503-1506.
18. Timofeyev Y., Jakovljevic M. Fraudster’s and victims’ profiles and loss predictors’ hierarchy in the mental healthcare industry in the US. Journal of Medical Economics. 2020; 23(10): 1111-1122.
19. Peltier-Rivest, D. The prevention and detection of corruption in pharmaceutical companies. Pharmaceuticals Policy and Law. 2017; 19(1-2): 17-31.
20. Timofeyev Y. Analysis of predictors of organizational losses due to occupational corruption. International Business Review. 2015; 24(4): 630-641.
21. Peugh J.L. A practical guide to multilevel modeling. Journal of School Psychology. 2010; 48(1): 85-112.
22. Ejakait E., Olel M., Othuon L., Khasenye O. A hierarchical linear modelling of teacher effects on academic achievement in the Kenya certificate of primary education examination. American Journal of Educational Research. 2016; 4(14): 1030-1040. Available at: http://pubs.sciepub.com/education/4/14/8/.
23. Efron B. Bootstrap methods: another look at the jackknife. Annals of Statistics. 1979; 7(1): 1–26. Available at: http://www.jstor.org/stable/2958830.
24. Kosowski R., Timmermann A., Wermers R., White H. Can mutual fund “stars” really pick stocks? New evidence from a bootstrap analysis. The Journal of Finance. 2006; 61: 2551-2595
25. Carpenter J. R., Kenward M.G. Multiple imputation of quantitative data. Multiple Imputation and its Application. 2013: 75-89.
26. U.S. Food & Drug Administration. Federal Food, Drug and Cosmetic Act. 2018. Available at: https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act
27. Wells J.T. Six common myths about fraud. Journal of Accountancy. 1990: 82-88
28. Kalovya O. Z. Determinants of occupational fraud losses: offenders, victims and insights from fraud theory. Journal of Financial Crime. 2020. https://doi.org/10.1108/JFC-10-2019-0136
29. Błaszczyński J., de Almeida Filho A.T., Matuszyk A., Szeląg M., Słowiński R. Auto loan fraud detection using dominance-based rough set approach versus machine learning methods. Expert Systems with Applications. 2021; 163, 113740.
30. U.S. Trade Commission. 2010. https://www.usitc.gov/publications/332/pub4125.pdf
31. Krishnan, G., Peytcheva M. The risk of fraud in family firms: Assessments of external auditors. Journal of Business Ethics. 2019; (157)1: 261-278.
32. Association of Certified Fraud Examiners. 2016 Report to the Nations on Occupational Fraud and Abuse. Austin: ACFE; 2016. Available from: www.acfe.com/rttn2016/docs/2016-report-to-thenations.pdf
33. Denman D.E. 2018 Report on Occupational Fraud: Results and how companies can protect their assets. Journal of Accounting and Finance. 2019; 19(4): 97-112. Available at: https://doi.org/10.33423/jaf.v19i4.2175
34. Association of Certified Fraud Examiners. 2018 Report to the Nations: Global Study on Occupational Fraud and Abuse. Austin: ACFE; 2018. Available at: https://s3-us-west-2.amazonaws.com/acfepublic/2018-report-to-the-nations.pdf
35. Academy of Managed Care Pharmacists. Fraud, Waste, and Abuse in Prescription Drug Benefits. 2019. Posted May 20. https://www.amcp.org/policy-advocacy/policy-advocacy-focus-areas/where-we-stand-position-statements/fraud-waste-and-abuse-prescription-drug-benefits
36. Statista. Prescription drug expenditure in the United States from 1960 to 2020. 2021. Available at: https://www.statista.com/statistics/184914/prescription-drug-expenditures-in-the-us-since-1960/